🔴 Structure Therapeutics is trading 5% down in pre-market as catalyst remains unclear

Structure Therapeutics is trading 5.17% lower at $35.00 in pre-market, with the catalyst unclear.

• No clear company-specific announcement, earnings release, analyst action or insider-sale catalyst was identified for September 23, 2026.
• Available coverage lists the latest company-specific clinical-data news as approximately nine days old and gives no reason for the overnight decline.
• Biotechnology is higher pre-market, while major U.S. indices are only modestly mixed.